Page last updated: 2024-10-16

carnitine and Endocardial Fibroelastosis

carnitine has been researched along with Endocardial Fibroelastosis in 4 studies

Endocardial Fibroelastosis: A condition characterized by the thickening of ENDOCARDIUM due to proliferation of fibrous and elastic tissue, usually in the left ventricle leading to impaired cardiac function (CARDIOMYOPATHY, RESTRICTIVE). It is most commonly seen in young children and rarely in adults. It is often associated with congenital heart anomalies (HEART DEFECTS CONGENITAL;) INFECTION; or gene mutation. Defects in the tafazzin protein, encoded by TAZ gene, result in a form of autosomal dominant familial endocardial fibroelastosis.

Research Excerpts

ExcerptRelevanceReference
"Endocardial fibroelastosis (EFE) has previously been shown to be associated with tissue carnitine deficiency, although the basis for the carnitine deficiency has not been documented."7.69Endocardial fibroelastosis and primary carnitine deficiency due to a defect in the plasma membrane carnitine transporter. ( Bennett, MJ; Hale, DE; Pollitt, RJ; Stanley, CA; Variend, S, 1996)
"Endocardial fibroelastosis (EFE) has previously been shown to be associated with tissue carnitine deficiency, although the basis for the carnitine deficiency has not been documented."3.69Endocardial fibroelastosis and primary carnitine deficiency due to a defect in the plasma membrane carnitine transporter. ( Bennett, MJ; Hale, DE; Pollitt, RJ; Stanley, CA; Variend, S, 1996)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19903 (75.00)18.7374
1990's1 (25.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tripp, ME1
Katcher, ML1
Peters, HA1
Gilbert, EF1
Arya, S1
Hodach, RJ1
Shug, AL1
Bennett, MJ1
Hale, DE1
Pollitt, RJ1
Stanley, CA1
Variend, S1
Hanukoglu, A1
Fried, D1
Somekh, E1
Rabinovitch, MA1
Kalff, V1
Allen, R1
Rosenthal, A1
Albers, J1
Das, SK1
Pitt, B1
Swanson, DP1
Mangner, T1
Rogers, WL1

Other Studies

4 other studies available for carnitine and Endocardial Fibroelastosis

ArticleYear
Systemic carnitine deficiency presenting as familial endocardial fibroelastosis: a treatable cardiomyopathy.
    The New England journal of medicine, 1981, Aug-13, Volume: 305, Issue:7

    Topics: Administration, Oral; Carnitine; Child; Endocardial Fibroelastosis; Female; Humans; Infant; Infant,

1981
Endocardial fibroelastosis and primary carnitine deficiency due to a defect in the plasma membrane carnitine transporter.
    Clinical cardiology, 1996, Volume: 19, Issue:3

    Topics: Cardiomyopathy, Dilated; Carnitine; Cell Membrane; Endocardial Fibroelastosis; Female; Fibroblasts;

1996
Inheritance of familial primary endocardial fibroelastosis.
    Clinical pediatrics, 1986, Volume: 25, Issue:5

    Topics: Carnitine; Digoxin; Endocardial Fibroelastosis; Female; HLA Antigens; Humans; Infant; Infant, Newbor

1986
omega-123I-hexadecanoic acid metabolic probe of cardiomyopathy.
    European journal of nuclear medicine, 1985, Volume: 10, Issue:5-6

    Topics: Adolescent; Adult; Aged; Alcoholism; Atrial Fibrillation; Cardiomyopathies; Cardiomyopathy, Dilated;

1985